Pediatric Hematology & Oncology

Medicine & Life Sciences

1. Rhabdomyosarcoma 100%
2. Phosphotransferases 98%
3. Medulloblastoma 84%
4. Pediatrics 71%
5. Calcium-Calmodulin-Dependent Protein Kinase Type 1 63%
6. Neoplasms 61%
7. Calcium-Calmodulin-Dependent Protein Kinases 60%
8. Sarcoma 59%
9. Mutation 53%
10. Embryonal Rhabdomyosarcoma 50%
11. Calcium-Calmodulin-Dependent Protein Kinase Kinase 48%
12. Alveolar Rhabdomyosarcoma 47%
13. Crizotinib 45%
14. Neurons 43%
15. Oncogene Fusion 41%
16. Therapeutics 40%
17. Humanism 38%
18. entinostat 37%
19. Phosphorylation 35%
20. Spine 35%
21. Heterografts 34%
22. Cell Transplantation 32%
23. Protein Kinases 31%
24. Cyclic AMP-Dependent Protein Kinases 31%
25. Professionalism 30%
26. Severe Combined Immunodeficiency 29%
27. Child 29%
28. Leukemia 28%
29. Hematology 28%
30. entrectinib 28%
31. Bortezomib 28%
32. Bone Marrow 28%
33. Oncogenes 27%
34. Hippocampus 27%
35. Dendritic Spines 26%
36. Thrombosis 26%
37. GSK 1363089 26%
38. CPI203 26%
39. Long-Term Potentiation 26%
40. Anaplastic Lymphoma Kinase 25%
41. Extracellular Signal-Regulated MAP Kinases 24%
42. tandutinib 23%
43. Growth 23%
44. NP 031112 23%
45. Hematologic Neoplasms 23%
46. calmodulin dependent protein kinase II phosphatase 22%
47. Immune Reconstitution 22%
48. Protein-Tyrosine Kinases 22%
49. L-Type Calcium Channels 22%
50. cabozantinib 21%
51. Lung Neoplasms 21%
52. Glioma 21%
53. mitogen and stress-activated protein kinase 1 21%
54. MicroRNAs 20%
55. A Kinase Anchor Proteins 20%
56. Cell Line 20%
57. Survival 19%
58. Proteins 19%
59. Genes 19%
60. Diffuse Intrinsic Pontine Glioma 19%
61. Embryonic Structures 18%
62. Interleukin-13 Receptors 18%
63. Venous Thromboembolism 18%
64. Anhidrotic Ectodermal Dysplasia 1 18%
65. Receptor Protein-Tyrosine Kinases 18%
66. p21-Activated Kinases 18%
67. Primary Immunodeficiency Diseases 18%
68. STO 609 17%
69. Interleukin-1 Receptor-Associated Kinases 17%
70. Thrombopoietin Receptors 17%
71. Phosphoric Monoester Hydrolases 17%
72. Skeletal Muscle 16%
73. Tomography 16%
74. Point Mutation 16%
75. Dystroglycans 16%
76. Cyclic AMP Response Element-Binding Protein 16%
77. Pseudopodia 16%
78. Osteopetrosis 16%
79. Genome 16%
80. 14-3-3 Proteins 15%
81. Acute Myeloid Leukemia 15%
82. Nerve Growth Factors 15%
83. Psychological Burnout 15%
84. Protein Phosphatase 1 15%
85. Growth Cones 15%
86. Glycogen Synthase Kinase 3 15%
87. Cholangiocarcinoma 15%
88. Glycosyltransferases 15%
89. Transplantation 15%
90. X-Ray Microtomography 15%
91. Pharmaceutical Preparations 15%
92. Menorrhagia 14%
93. Tensins 14%
94. Chiroptera 14%
95. Synapses 14%
96. Levonorgestrel 14%
97. Breast Neoplasms 14%
98. Carrier Proteins 14%
99. Polyadenylation 14%
100. Physicians 14%